Digital Health Global

APRIL 25, 2024

The study, led by principal investigator Nitin Ohri, M.D., This pilot study represents a critical step in leveraging digital health technology to enhance cancer treatment outcomes,” said John Wagner, M.D., Chief Medical Officer, Koneksa. Chief Medical Officer, Koneksa. “By

Health Data 88

Health Data BioTech Drug Development healthcare technology 88

Digital Health Global

JANUARY 4, 2024

Koneksa’s innovative digital model aims to address limitations in existing functional status assessments by leveraging digital health technologies (DHTs) for both objective and self-reported outcomes. Up to 25 patients will be enrolled in this clinical validation study of 24/7 functional status in orthopedics (hip replacements).

Digital Health 88

Digital Health Health Technology Drug Development healthcare technology 88

Digital Health Global

JUNE 13, 2023

The LEARNS study will investigate the Koneksa neuroscience solution, as well as the Beacon Biosignals platform, applied to at-home EEG, compared with in-clinic polysomnography, in neurological and sleep disorders. Beacon’s mobile EEG will join more than a dozen digital health technologies that are already integrated into the Koneksa solution.

Drug Development 88

Drug Development eMed BioTech Digital Health 88